Dr. Farkouh specializes in diabetes and cardiovascular disease clinical trials. In his new role, he will be responsible for creating growth opportunities, ensuring optimal infrastructure and leading strategic planning for Cedars-Sinai.
Most recently, Dr. Farkouh served as the director of clinical trials at the cardiovascular research institute at Mount Sinai Health System in New York City.
“We look forward to Dr. Farkouh joining Cedars-Sinai and leading the continued expansion of our fast-growing academic programs,” Jeffrey Golden, MD, vice dean of research and graduate education and director of the Burns and Allen Research Institute at Cedars-Sinai, said in a Jan. 18 press release. “As associate dean for research and clinical trials, Dr. Farkouh will support our academic enterprise with a particular focus on expanding clinical trials in all disciplines.”
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
